Thalicarpine is a natural aporphine benzylisoquinoline vinca alkaloid with antineoplastic activity. Thalicarpine binds to and inhibits p-glycoprotein, the multidrug resistance efflux pump. Thalicarpine also induces single-strand breaks in DNA and arrests cancer cells at the G2 M and G1 phase of the cell cycle. Check for active clinical trials or closed clinical trials using this agent.
Milataxel is an orally bioavailable taxane with potential antineoplastic activity. Upon oral administration, milataxel and its major active metabolite M-10 bind to and stabilize tubulin, resulting in the inhibition of microtubule depolymerization and cell division, cell cycle arrest in the G2 M phase, and the inhibition of tumor cell proliferation. Unlike other taxane compounds, milataxel appears to be a poor substrate for the multidrug resistance (MDR) membrane-associated P-glycoprotein (P-gp) efflux pump and may be useful for treating multidrug-resistant tumors. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus).This compound is unstable in powder form and other related salt forms are recommended.
Tubulin inhibitor 1 is an inhibitor of tubulin, inhibits tubulin polymerization, with potent anti-tumor activity, induces cellular apoptosis causes and cellular mitotic arrest in the G2 M phase.
XSJ05,一种喜树碱 (CPT) 衍生物,能有效抑制拓扑异构酶 I (Topo I) 以发挥抗癌作用。该化合物能促使 DNA 双链断裂,进而引起 DNA 损伤。此外,XSJ05 对抑制结直肠癌 (CRC) 生长具有显著效果,能使细胞周期在 G2 M 期暂停,并能诱导细胞凋亡 (apoptosis)。